Outlook Therapeutics (OTLK) Change in Receivables: 2015-2016
Historic Change in Receivables for Outlook Therapeutics (OTLK) over the last 2 years, with Sep 2016 value amounting to -$3,670.
- Outlook Therapeutics' Change in Receivables rose 93.06% to -$3,670 in Q3 2016 from the same period last year, while for Sep 2016 it was -$20,000, marking a year-over-year change of. This contributed to the annual value of -$20,000 for FY2016, which is 200.00% down from last year.
- Outlook Therapeutics' Change in Receivables amounted to -$3,670 in Q3 2016, which was up 99.27% from -$501,187 recorded in Q2 2016.
- Over the past 5 years, Outlook Therapeutics' Change in Receivables peaked at $401,767 during Q1 2016, and registered a low of -$1.0 million during Q2 2015.
- Its 2-year average for Change in Receivables is -$178,818, with a median of -$28,290 in 2015.
- Data for Outlook Therapeutics' Change in Receivables shows a peak YoY surged of 93.06% (in 2016) over the last 5 years.
- Over the past 2 years, Outlook Therapeutics' Change in Receivables (Quarterly) stood at $83,090 in 2015, then surged by 93.06% to -$3,670 in 2016.
- Its last three reported values are -$3,670 in Q3 2016, -$501,187 for Q2 2016, and $401,767 during Q1 2016.